Report Detail
Global Microbial Polysaccharides for Pharmaceutical Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4737759 |
- 08 September, 2026 |
- Global |
- 122 Pages |
- GIR |
- Chemical & Material
According to our (Global Info Research) latest study, the global Microbial Polysaccharides for Pharmaceutical market size was valued at US$ 218 million in 2025 and is forecast to a readjusted size of US$ 298 million by 2032 with a CAGR of 4.6% during review period.
Microbial polysaccharides for pharmaceutical refer to polysaccharides produced by bacteria, yeasts or filamentous fungi via controlled fermentation and subsequently purified to pharmaceutical or medical-device grade, where they are used as excipients, biomaterials or active ingredients in human and veterinary medicines. Typical examples include xanthan gum, gellan gum, dextran, pullulan and related microbial exopolysaccharides.
Upstream, these materials rely on fermentation substrates (starch hydrolysates, glucose, sucrose), nitrogen sources (corn steep liquor, ammonium salts, yeast extract), process aids and selected high-yield microbial strains. Downstream, pharmaceutical-grade microbial polysaccharides flow into: parenteral products, solid and liquid dosage forms, biomedical materials.
In 2024, global sales of microbial polysaccharides for pharmaceutical reached approximately 23 K tons, with an average global market price of around US$8,767/ton. Production capacity varies significantly among manufacturers, with gross profit margins ranging from approximately 30% to 60%.
In pharmaceutical and biomedical fields, the strategic relevance of microbial polysaccharides is becoming more pronounced. Numerous studies indicate that exopolysaccharides exhibit excellent biocompatibility and degradability, together with a wide range of bioactivities such as immunomodulation, antioxidant effects and promotion of tissue repair, which gives them clear advantages in drug-controlled-release matrices, tissue-engineering scaffolds, wound dressings, cell encapsulation and three-dimensional culture systems. As demand rises for advanced formulations, regenerative medicine and precision therapies, high-purity grades of dextran, xanthan gum, pullulan and modified EPS are progressively penetrating high-value medical and health-care applications, becoming a key driver for the industry’s move up the value chain.
At the same time, the market still faces several structural challenges and directions for evolution. On one hand, compared with starch-based and some synthetic polymers, microbial polysaccharides typically require longer fermentation cycles and more complex downstream purification, which makes certain products relatively cost-sensitive in bulk industrial uses; this is pushing producers to raise volumetric productivity, valorize by-products and adopt lower-cost carbon sources in order to relieve cost pressure. On the other hand, tightening environmental and regulatory expectations are encouraging companies to reinforce their sustainability strategies, including the use of agricultural residues or by-products as substrates, reduction of organic-solvent usage, and development of polysaccharide-based materials that are easier to recycle and biodegrade. Overall, microbial polysaccharides are expected to evolve along a path of “structure designability – application specialization – green production”, with the market structure gradually stabilizing into a balance between integrated leaders and specialized players focused on narrow but high-value niches.
This report is a detailed and comprehensive analysis for global Microbial Polysaccharides for Pharmaceutical market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Microbial Polysaccharides for Pharmaceutical market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Microbial Polysaccharides for Pharmaceutical market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Microbial Polysaccharides for Pharmaceutical market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Microbial Polysaccharides for Pharmaceutical market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Microbial Polysaccharides for Pharmaceutical
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Microbial Polysaccharides for Pharmaceutical market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pharmacosmos, Magle Biopolymers, CP Kelco, Deosen Biochemical, Nagase Viita, Jianlong Biotechnology, Jungbunzlauer, Meito Sangyo, Polydex Pharmaceuticals, Shandong Freda Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Microbial Polysaccharides for Pharmaceutical market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Xanthan Gum
Gellan Gum
Pullulan
Curdlan Gum
Other
Market segment by Molecular Structure
Homopolysaccharides
Heteropolysaccharides
Market segment by Ionic Charge
Anionic
Neutral
Cationic
Market segment by Application
Injection and Infusion
Oral Drugs
Topical Medicine
Eye Drops
Other
Major players covered
Pharmacosmos
Magle Biopolymers
CP Kelco
Deosen Biochemical
Nagase Viita
Jianlong Biotechnology
Jungbunzlauer
Meito Sangyo
Polydex Pharmaceuticals
Shandong Freda Biotechnology
Shandong Kangnaxin Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Microbial Polysaccharides for Pharmaceutical product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Microbial Polysaccharides for Pharmaceutical, with price, sales quantity, revenue, and global market share of Microbial Polysaccharides for Pharmaceutical from 2021 to 2026.
Chapter 3, the Microbial Polysaccharides for Pharmaceutical competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Microbial Polysaccharides for Pharmaceutical breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Microbial Polysaccharides for Pharmaceutical market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Microbial Polysaccharides for Pharmaceutical.
Chapter 14 and 15, to describe Microbial Polysaccharides for Pharmaceutical sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Microbial Polysaccharides for Pharmaceutical Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Xanthan Gum
- 1.3.3 Gellan Gum
- 1.3.4 Pullulan
- 1.3.5 Curdlan Gum
- 1.3.6 Other
- 1.4 Market Analysis by Molecular Structure
- 1.4.1 Overview: Global Microbial Polysaccharides for Pharmaceutical Consumption Value by Molecular Structure: 2021 Versus 2025 Versus 2032
- 1.4.2 Homopolysaccharides
- 1.4.3 Heteropolysaccharides
- 1.5 Market Analysis by Ionic Charge
- 1.5.1 Overview: Global Microbial Polysaccharides for Pharmaceutical Consumption Value by Ionic Charge: 2021 Versus 2025 Versus 2032
- 1.5.2 Anionic
- 1.5.3 Neutral
- 1.5.4 Cationic
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Microbial Polysaccharides for Pharmaceutical Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Injection and Infusion
- 1.6.3 Oral Drugs
- 1.6.4 Topical Medicine
- 1.6.5 Eye Drops
- 1.6.6 Other
- 1.7 Global Microbial Polysaccharides for Pharmaceutical Market Size & Forecast
- 1.7.1 Global Microbial Polysaccharides for Pharmaceutical Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Microbial Polysaccharides for Pharmaceutical Sales Quantity (2021-2032)
- 1.7.3 Global Microbial Polysaccharides for Pharmaceutical Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Pharmacosmos
- 2.1.1 Pharmacosmos Details
- 2.1.2 Pharmacosmos Major Business
- 2.1.3 Pharmacosmos Microbial Polysaccharides for Pharmaceutical Product and Services
- 2.1.4 Pharmacosmos Microbial Polysaccharides for Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Pharmacosmos Recent Developments/Updates
- 2.2 Magle Biopolymers
- 2.2.1 Magle Biopolymers Details
- 2.2.2 Magle Biopolymers Major Business
- 2.2.3 Magle Biopolymers Microbial Polysaccharides for Pharmaceutical Product and Services
- 2.2.4 Magle Biopolymers Microbial Polysaccharides for Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Magle Biopolymers Recent Developments/Updates
- 2.3 CP Kelco
- 2.3.1 CP Kelco Details
- 2.3.2 CP Kelco Major Business
- 2.3.3 CP Kelco Microbial Polysaccharides for Pharmaceutical Product and Services
- 2.3.4 CP Kelco Microbial Polysaccharides for Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 CP Kelco Recent Developments/Updates
- 2.4 Deosen Biochemical
- 2.4.1 Deosen Biochemical Details
- 2.4.2 Deosen Biochemical Major Business
- 2.4.3 Deosen Biochemical Microbial Polysaccharides for Pharmaceutical Product and Services
- 2.4.4 Deosen Biochemical Microbial Polysaccharides for Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Deosen Biochemical Recent Developments/Updates
- 2.5 Nagase Viita
- 2.5.1 Nagase Viita Details
- 2.5.2 Nagase Viita Major Business
- 2.5.3 Nagase Viita Microbial Polysaccharides for Pharmaceutical Product and Services
- 2.5.4 Nagase Viita Microbial Polysaccharides for Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Nagase Viita Recent Developments/Updates
- 2.6 Jianlong Biotechnology
- 2.6.1 Jianlong Biotechnology Details
- 2.6.2 Jianlong Biotechnology Major Business
- 2.6.3 Jianlong Biotechnology Microbial Polysaccharides for Pharmaceutical Product and Services
- 2.6.4 Jianlong Biotechnology Microbial Polysaccharides for Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Jianlong Biotechnology Recent Developments/Updates
- 2.7 Jungbunzlauer
- 2.7.1 Jungbunzlauer Details
- 2.7.2 Jungbunzlauer Major Business
- 2.7.3 Jungbunzlauer Microbial Polysaccharides for Pharmaceutical Product and Services
- 2.7.4 Jungbunzlauer Microbial Polysaccharides for Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Jungbunzlauer Recent Developments/Updates
- 2.8 Meito Sangyo
- 2.8.1 Meito Sangyo Details
- 2.8.2 Meito Sangyo Major Business
- 2.8.3 Meito Sangyo Microbial Polysaccharides for Pharmaceutical Product and Services
- 2.8.4 Meito Sangyo Microbial Polysaccharides for Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Meito Sangyo Recent Developments/Updates
- 2.9 Polydex Pharmaceuticals
- 2.9.1 Polydex Pharmaceuticals Details
- 2.9.2 Polydex Pharmaceuticals Major Business
- 2.9.3 Polydex Pharmaceuticals Microbial Polysaccharides for Pharmaceutical Product and Services
- 2.9.4 Polydex Pharmaceuticals Microbial Polysaccharides for Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Polydex Pharmaceuticals Recent Developments/Updates
- 2.10 Shandong Freda Biotechnology
- 2.10.1 Shandong Freda Biotechnology Details
- 2.10.2 Shandong Freda Biotechnology Major Business
- 2.10.3 Shandong Freda Biotechnology Microbial Polysaccharides for Pharmaceutical Product and Services
- 2.10.4 Shandong Freda Biotechnology Microbial Polysaccharides for Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Shandong Freda Biotechnology Recent Developments/Updates
- 2.11 Shandong Kangnaxin Biotechnology
- 2.11.1 Shandong Kangnaxin Biotechnology Details
- 2.11.2 Shandong Kangnaxin Biotechnology Major Business
- 2.11.3 Shandong Kangnaxin Biotechnology Microbial Polysaccharides for Pharmaceutical Product and Services
- 2.11.4 Shandong Kangnaxin Biotechnology Microbial Polysaccharides for Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Shandong Kangnaxin Biotechnology Recent Developments/Updates
3 Competitive Environment: Microbial Polysaccharides for Pharmaceutical by Manufacturer
- 3.1 Global Microbial Polysaccharides for Pharmaceutical Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Microbial Polysaccharides for Pharmaceutical Revenue by Manufacturer (2021-2026)
- 3.3 Global Microbial Polysaccharides for Pharmaceutical Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Microbial Polysaccharides for Pharmaceutical by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Microbial Polysaccharides for Pharmaceutical Manufacturer Market Share in 2025
- 3.4.3 Top 6 Microbial Polysaccharides for Pharmaceutical Manufacturer Market Share in 2025
- 3.5 Microbial Polysaccharides for Pharmaceutical Market: Overall Company Footprint Analysis
- 3.5.1 Microbial Polysaccharides for Pharmaceutical Market: Region Footprint
- 3.5.2 Microbial Polysaccharides for Pharmaceutical Market: Company Product Type Footprint
- 3.5.3 Microbial Polysaccharides for Pharmaceutical Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Microbial Polysaccharides for Pharmaceutical Market Size by Region
- 4.1.1 Global Microbial Polysaccharides for Pharmaceutical Sales Quantity by Region (2021-2032)
- 4.1.2 Global Microbial Polysaccharides for Pharmaceutical Consumption Value by Region (2021-2032)
- 4.1.3 Global Microbial Polysaccharides for Pharmaceutical Average Price by Region (2021-2032)
- 4.2 North America Microbial Polysaccharides for Pharmaceutical Consumption Value (2021-2032)
- 4.3 Europe Microbial Polysaccharides for Pharmaceutical Consumption Value (2021-2032)
- 4.4 Asia-Pacific Microbial Polysaccharides for Pharmaceutical Consumption Value (2021-2032)
- 4.5 South America Microbial Polysaccharides for Pharmaceutical Consumption Value (2021-2032)
- 4.6 Middle East & Africa Microbial Polysaccharides for Pharmaceutical Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Microbial Polysaccharides for Pharmaceutical Sales Quantity by Type (2021-2032)
- 5.2 Global Microbial Polysaccharides for Pharmaceutical Consumption Value by Type (2021-2032)
- 5.3 Global Microbial Polysaccharides for Pharmaceutical Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Microbial Polysaccharides for Pharmaceutical Sales Quantity by Application (2021-2032)
- 6.2 Global Microbial Polysaccharides for Pharmaceutical Consumption Value by Application (2021-2032)
- 6.3 Global Microbial Polysaccharides for Pharmaceutical Average Price by Application (2021-2032)
7 North America
- 7.1 North America Microbial Polysaccharides for Pharmaceutical Sales Quantity by Type (2021-2032)
- 7.2 North America Microbial Polysaccharides for Pharmaceutical Sales Quantity by Application (2021-2032)
- 7.3 North America Microbial Polysaccharides for Pharmaceutical Market Size by Country
- 7.3.1 North America Microbial Polysaccharides for Pharmaceutical Sales Quantity by Country (2021-2032)
- 7.3.2 North America Microbial Polysaccharides for Pharmaceutical Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Microbial Polysaccharides for Pharmaceutical Sales Quantity by Type (2021-2032)
- 8.2 Europe Microbial Polysaccharides for Pharmaceutical Sales Quantity by Application (2021-2032)
- 8.3 Europe Microbial Polysaccharides for Pharmaceutical Market Size by Country
- 8.3.1 Europe Microbial Polysaccharides for Pharmaceutical Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Microbial Polysaccharides for Pharmaceutical Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Microbial Polysaccharides for Pharmaceutical Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Microbial Polysaccharides for Pharmaceutical Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Microbial Polysaccharides for Pharmaceutical Market Size by Region
- 9.3.1 Asia-Pacific Microbial Polysaccharides for Pharmaceutical Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Microbial Polysaccharides for Pharmaceutical Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Microbial Polysaccharides for Pharmaceutical Sales Quantity by Type (2021-2032)
- 10.2 South America Microbial Polysaccharides for Pharmaceutical Sales Quantity by Application (2021-2032)
- 10.3 South America Microbial Polysaccharides for Pharmaceutical Market Size by Country
- 10.3.1 South America Microbial Polysaccharides for Pharmaceutical Sales Quantity by Country (2021-2032)
- 10.3.2 South America Microbial Polysaccharides for Pharmaceutical Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Microbial Polysaccharides for Pharmaceutical Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Microbial Polysaccharides for Pharmaceutical Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Microbial Polysaccharides for Pharmaceutical Market Size by Country
- 11.3.1 Middle East & Africa Microbial Polysaccharides for Pharmaceutical Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Microbial Polysaccharides for Pharmaceutical Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Microbial Polysaccharides for Pharmaceutical Market Drivers
- 12.2 Microbial Polysaccharides for Pharmaceutical Market Restraints
- 12.3 Microbial Polysaccharides for Pharmaceutical Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Microbial Polysaccharides for Pharmaceutical and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Microbial Polysaccharides for Pharmaceutical
- 13.3 Microbial Polysaccharides for Pharmaceutical Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Microbial Polysaccharides for Pharmaceutical Typical Distributors
- 14.3 Microbial Polysaccharides for Pharmaceutical Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Microbial Polysaccharides for Pharmaceutical. Industry analysis & Market Report on Microbial Polysaccharides for Pharmaceutical is a syndicated market report, published as Global Microbial Polysaccharides for Pharmaceutical Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Microbial Polysaccharides for Pharmaceutical market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
